Tag Archives: Medicaid Drug Rebate Program

Life Sciences Health Industry Group Winter 2015/2016 Course Offerings

The Reed Smith Life Sciences Health Industry Group (LSHI) recently released their “Winter 2015/2016 Webinar Course Offerings,” which once again features timely webinars and in-person programs on a wide variety of topics. Upcoming events include: January 19, 2016 – Webinar: The Good, the Bad and the Ugly: The Best and Worst Prescription Drug/Medical Device January 24, … Continue Reading

Proposed Budget Deal Would Add Medicaid Inflation Rebates for Generic Drugs

As noted in our recent Health Industry Washington Watch blog post, outgoing House Speaker John Boehner and the Obama Administration have reached agreement on a two-year, $80 billion budget/debt-ceiling deal that includes Medicare and Medicaid “offsets” to finance other spending.  For manufacturers of generic pharmaceuticals marketed under abbreviated new drug applications, Section 602 of the proposed … Continue Reading

CMS Releases Long-Awaited Proposed Rule to Implement ACA Medicaid Manufacturer Rebate and Pharmacy Reimbursement Provisions

On Friday, January 27, 2012, the Centers for Medicare & Medicaid Services ("CMS") released its long-awaited proposed rule to implement the provisions of the Affordable Care Act ("ACA") relating to pharmaceutical manufacturer payment of Medicaid rebates and limits on Medicaid reimbursement to pharmacies. The proposed rule addresses a number of important policy issues relevant to pharmaceutical manufacturers, pharmacies, and other providers, and also would pose significant operational challenges for pharmaceutical manufacturers with respect to the Medicaid Drug Rebate Program ("MDRP").… Continue Reading
LexBlog